Trial
NCT03060772
A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Alcoholism
Intervention
Pioglitazone
Why stopped
Study was suspended in 2020 due to COVID-19 pandemic as a result of recruitment challenges and the inability to conduct all study procedures (e.g., bronchoscopy) per protocol. In late 2021 the decision was made to not re-open the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-02-14